SEP 09, 2021 5:00 PM PDT

Can vaccines help prevent and treat opioid addiction?

WRITTEN BY: J. Bryce Ortiz

According to the United States Centers for Disease Control (CDC), 136 people die from an opioid overdose every day. The most recent data show that 70,630 people died in 2019 from opioid drug overdose. When this number of overdose deaths from 2019 is compared to overdose deaths from 2013, this reflects a nearly 1,040% increase in opioid related deaths. This sharp increase in death rate highlights the expanding opioid drug abuse epidemic plaguing the United States. 

The U.S. Department of Health and Human Services estimates that in the year 2019, approximately 10.1 million people, aged 12 or older, abused opioids. Many opioids are prescribed to individuals to treat pain such as following a surgery or accident. However, opioids can be highly addictive and once opioid dependence develops, withdrawal from opioids can lead to undesirable symptoms that interfere with daily life. As such, individuals will often continue using opioids even after a prescription has ended. This is highlighted by the fact that 80 percent of people who abuse heroin started first misusing prescription opioids. Current protocols focus on behavioral interventions for opioid use prevention, or rehabilitation services for individuals who are currently addicted. However, a recently approved clinical trial is testing whether vaccines can prevent opioid abuse. 

In this clinical trial, researchers are testing whether vaccines can help prevent the drugs oxycodone and heroin from being abused. These vaccines were recently developed and essentially work to boost specific types of antibodies that can recognize oxycodone or heroin as they enter the body. As such, if an individual who receives these vaccinations takes the drugs oxycodone or heroin, the antibodies recognize the drugs, bind them, and prevent them from entering into the brain. As the drugs are unable to reach the brain, this prevents the feelings of euphoria that come with drug abuse. Dr. Sandra Comer, a lead researcher on the clinical trial said, “[these vaccines] could help many more people beat their addiction and potentially protect them from an overdose death if a patient relapses.”

While the vaccines have yet to be tested in humans, they have shown high efficacy in preclinical rodent studies. In one study, the vaccines were administered to rats and it was found that the vaccines reduced the addictive potential of oxycodone and heroin, and that the effects of the vaccines were long lasting, lasting for approximately 2-3 months after a single injection. The vaccines are currently undergoing clinical testing in order to determine their effectiveness in humans. But, if they prove effective, these vaccines will be pivotal instruments in saving millions lives and preventing addiction. 

 

 

Sources: CDCHHSNIHMolecular PharmaceuticsNeuropharmacology

About the Author
  • Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
AUG 01, 2021
Drug Discovery & Development
Berry Compound Reverses Parkinson's in Mice
AUG 01, 2021
Berry Compound Reverses Parkinson's in Mice
A naturally-occurring compound called farnesol found in berries and other fruits prevents and reverses Parkinson's-a ...
AUG 12, 2021
Immunology
Anticoagulants Target a Weak Spot in Coronavirus Variants
AUG 12, 2021
Anticoagulants Target a Weak Spot in Coronavirus Variants
Australian researchers have found a new molecular binding site on the coronavirus that causes COVID-19, a discovery that ...
AUG 10, 2021
Immunology
A Tapeworm Drug as a COVID Antiviral?
AUG 10, 2021
A Tapeworm Drug as a COVID Antiviral?
A study by researchers at the Scripps Research Institute looking into potential COVID-19 medications has revealed a surp ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
AUG 18, 2021
Cannabis Sciences
Cancer Patients Use Less Cannabis than General Public
AUG 18, 2021
Cancer Patients Use Less Cannabis than General Public
Despite increasing legalization for recreational cannabis across the US, cancer patients have largely abstained from usi ...
OCT 07, 2021
Drug Discovery & Development
Extended approval for a drug to treat children living with HIV
OCT 07, 2021
Extended approval for a drug to treat children living with HIV
On Monday October 4th, ViiV Healthcare announced that it had submitted an application to the United States Food and Drug ...
Loading Comments...